We provide the first data that cathepsin B (Cath B), a lysosomal cysteine protease, is up-regulated following contusionspinal cord injury (SCI). Following T12 laminectomy and moderate contusion, Cath B mRNA and protein expression profiles were examined from 2 to 168 h post-injury in rats using real-time PCR and immunoblots, respectively. Contusion injury significantly increased [mRNA] Cath B in the injury site and adjacent segments over sham injury levels. While the largest [mRNA] Cath B induction (20-fold over naive) was seen in the injury site, the caudal segment routinely yielded [mRNA] Cath B levels greater than 10-fold over naive. Interestingly, sham injury animals also experienced mRNA induction at several time points at the injury site and in segments rostral and caudal to the injury site. Contusion injury also significantly elevated levels of Cath B proenzyme protein (37 kDa) over sham injury in the injury site (48, 72 and 168 h post-injury). Furthermore, significant protein increases of single and double chain Cath B (both active forms) occurred at the injury site at 72 and 168 h post-injury. Similar significant increases in Cath B protein levels were seen in areas adjacent to the injury site. The induction of Cath B mRNA and protein expression following contusion injury is previously undescribed and suggests that Cath B may potentially be involved in the secondary injury cascade, perhaps for as long as 1 week post-injury. Injury to the spinal cord is typically the result of some type of mechanical insult. This primary injury can be contusive, shearing, stretching or concussive in nature. Primary injury deforms neuronal cell bodies, axons and oligodendrocytes. Disruption of vascular elements and structures within injured tissue leads to petechial hemorrhage, the release of vasoactive molecules and loss of autoregulation by the vascular system (Anderson and Hall 1993; Amar and Levy 1999; Mautes et al. 2000) . The primary injury also initiates a cascade of pathochemical and pathophysiological events, collectively known as the secondary injury. These events include but are not limited to lipid hydrolysis, eicosanoid production, lipid peroxidation, loss of mitchondrial function and ionic homeostasis, invasion of neutrophils and macrophages, cytokine production, loss of the blood-spinal cord barrier integrity and excitotoxicity (Velardo et al. 1999; Demediuk et al. 1985 Demediuk et al. , 1987 Anderson and Hall 1993; Amar and Levy 1999; McGrath 1999; Lu et al. 2000) . Ultimately there is significant loss of neural tissue via apoptotic and necrotic cell death, which frequently results in cavitation around the injury site. As a result, there is a loss of function and sensation distal to the injury site and the prognosis for substantial functional recovery is usually poor.
Injury to the spinal cord is typically the result of some type of mechanical insult. This primary injury can be contusive, shearing, stretching or concussive in nature. Primary injury deforms neuronal cell bodies, axons and oligodendrocytes. Disruption of vascular elements and structures within injured tissue leads to petechial hemorrhage, the release of vasoactive molecules and loss of autoregulation by the vascular system (Anderson and Hall 1993; Amar and Levy 1999; Mautes et al. 2000) . The primary injury also initiates a cascade of pathochemical and pathophysiological events, collectively known as the secondary injury. These events include but are not limited to lipid hydrolysis, eicosanoid production, lipid peroxidation, loss of mitchondrial function and ionic homeostasis, invasion of neutrophils and macrophages, cytokine production, loss of the blood-spinal cord barrier integrity and excitotoxicity (Velardo et al. 1999; Demediuk et al. 1985 Demediuk et al. , 1987 Anderson and Hall 1993; Amar and Levy 1999; McGrath 1999; Lu et al. 2000) . Ultimately there is significant loss of neural tissue via apoptotic and necrotic cell death, which frequently results in cavitation around the injury site. As a result, there is a loss of function and sensation distal to the injury site and the prognosis for substantial functional recovery is usually poor.
There has been significant interest in understanding the activation and involvement of enzymatic cascades in the secondary injury response associated with trauma to the spinal cord. Several phospholipases, kinases, endonucleases and proteases are activated by injury-induced increases in intracellular Ca 2+ levels. Of these proteases, calpain and caspase, and now to some extent cathepsin B (Cath B), have been linked to neurodegeneration and cell death in multiple models of central nervous system (CNS) injury. The literature on calpain and caspase involvement in neurodegeneration is quite extensive. Calpain has been associated with tissue destruction and cell death in traumatic brain injury (Kampfl et al. 1996 (Kampfl et al. , 1997 Saatman et al. 1996) , ischemia (Rami and Krieglstein 1993; Bartus et al. 1994) and spinal cord injury (SCI) (Li et al. 1996; Ray et al. 1999 Ray et al. , 2000 Schumacher et al. 1999; Shields et al. 2000) . In these cases, the increases in calpain activity and immunoreactivity associated with injury are accompanied by increased breakdown of cytoskeletal and myelin proteins (Banik et al. 1997; Posmantur et al. 1998; Buki et al. 1999; Ray et al. 1999; Banik and Shields 2000) . With more than 40 reported substrates (Stroh and Schulze-Osthoff 1998) , caspases (predominantly caspase-3, 9 and -12) have also been linked to tissue loss and cell death in models of traumatic (Crowe et al. 1997; Liu et al. 1997; Keane et al. 2001; Larner et al. 2003) brain and spinal cord injury and in ischemic SCI Mackey et al. 1997; Hayashi et al. 1998; Matsushita et al. 2000) . Caspases were activated in models of global and focal brain ischemia (Chen et al. 1998; Fink et al. 1998; Namura et al. 1998; Ni et al. 1998; Didenko et al. 2002) . Furthermore, the inhibition of some caspase pathways reduced tissue damage and improved neurological functions (Cheng et al. 1998; Mouw et al. 2002) in rodent models of focal ischemia (reviewed by Robertson et al. 2000) .
To date, the role of Cath B in traumatic CNS insults has not been the focus of investigation. Under normal conditions, Cath B is synthesized as an inactive preproenzyme (39 kDa) in the trans-golgi, which is processed to the still inactive proenzyme (37 kDa) in the lysosomal compartment ( Fig. 1 ) (Mort and Buttle 1997) . Removal of the 63-residue propeptide from its N-terminal converts the inactive proenzyme to a single chain active form (30 kDa) (Fig. 1) . This single chain Cath B is further processed within the lysosome into a double chain form consisting of heavy (25 kDa) and light (5 kDa) components held together by a disulfide bond ( Fig. 1) (Mort and Buttle 1997) . Cath B is involved in protein turnover and digestion of cellular debris (Mort and Buttle 1997; Turk et al. 2000) and is capable of hydrolyzing carbohydrates, nucleic acids and lipids. Increased levels of Cath B expression and activity have been reported in several pathologies (Rempel et al. 1994; Berquin and Sloane 1996; Bever et al. 1997; Mackay et al. 1997; Kikuchi et al. 2003) including ischemia and oxidative stress (Kohda et al. 1996; Seyfried et al. 1997; Tsuchiya et al. 1999) . These changes in Cath B expression and activity are frequently accompanied by its redistribution from the lysosome to the cytosol, and in some cases to the nucleus (Roberts et al. 1997) in the injured tissues.
While Cath B has not been characterized following traumatic CNS injury, it has been well studied in a model of cerebral ischemic injury. Yamashima et al. (1996) found that the CA1 neuronal population in the hippocampus was completely obliterated five days following transient ischemia. In addition to increased levels of Cath B activity, the protein itself was also redistributed. The administration of two different Cath B inhibitors, CA-074 and E-64c, immediately following ischemia reduced enzyme activity, diminished Cath B immunoreactivity to near negligible levels and spared approximately 67 and 84%, respectively, of CA1 neurons from delayed neuronal death (Tsuchiya et al. 1999; Yamashima et al. 1998 Yamashima et al. , 1999 . These findings suggest that Cath B plays a role in the development of neuropathology following cerebral ischemia and that the inhibition of Cath B may represent a possible avenue for therapeutic intervention.
We propose that Cath B alone, and/or in conjunction with other proteases such as calpain and caspase, could be destructive in spinal cord tissue after injury. However, to date, the effects of contusion injury on Cath B expression levels have not been examined. Thus, the purpose of this study was to examine the effects of sham and contusion injury on expression of Cath B in the spinal cord. Our results demonstrate that contusion injury increased expression of both Cath B mRNA and protein in the injury site and in segments immediately rostral and caudal to the injury site.
Experimental procedures
All experimental procedures were conducted in accordance with the guidelines set forth by the University of Florida's Institute Animal Care and Use Committee (IACUC).
Laminectomy and injury
Female Long-Evans rats weighing approximately 230-300 g (Harlan, Indianapolis, IN, USA) were used in this study. All is synthesized on the rough ER where the signal peptide is cleaved cotranslationally. Following transport to the Golgi apparatus, the enzyme is glycosylated and the mannose-6-phosphate signal is assembled. This receptor allows for transport to the trans-Golgi network and then onto an acidic compartment where the pro-peptide is removed and enzyme is activated. Within the lysosome, the active single chain form of Cath B (30 kDa) is further modified (loss of a dipeptide) to produce the active double chain form (25 and 5 kDa) held together via disulfide bond.
surgical procedures were conducted under sterile conditions with supplemental heat. Intraperitoneal administration of nembutal (sodium pentobarbital, 50-60 mg/kg) was used to induce anesthesia. Following a T12, partial T11 laminectomy (intact dura mater), injury to the spinal cord was produced with an NYU impactor device (10 g, 25 mm). The sham injury animals received a laminectomy and were placed in the injury apparatus, but were not injured. The incisions were closed in layers. Animals were recovered in a heated incubator with food and water available ad libitum. Bladders were expressed and fluids were administered when required. In the immunoblot analysis (n ¼ 60), four animals were used for each treatment group (sham and contusion injury) at each time point (2, 6, 12, 24, 48, 72 , and 168 h post-injury). Four naive animals were also utilized. For the real-time PCR experiments (total n ¼ 44), both sham and contusion injury (n ¼ 3-6 each) were sacrificed at 2, 6, 24, 48, and 168 h post-injury in addition to a group (n ¼ 5) of naive animals. Spinal cord tissue was collected after extending the laminectomy to allow three segments of tissue to be removed: (i) rostral to injury site, (ii) injury site, and (iii) caudal to injury site. Each segment was approximately 6-7 mm in length. The fresh tissue was rinsed with cold 1 · phosphate-buffered saline (PBS) and either (i) homogenized with a guanidinum thiocyanate salt solution (500 lL) or (ii) flash frozen with liquid nitrogen. All samples were stored at ) 70°C until either (i) RNA isolation or (ii) protein homogenization.
RNA isolation and cDNA synthesis Total RNA isolation from the spinal cord tissue was achieved using a modified protocol, described by Earnhardt et al. (2002) , based on the guanidinium thiocyanate/phenol/chloroform extraction developed by Chomczynski and Sacchi (1987) . Final RNA concentrations were determined via spectrophotometry and samples were stored at )20°C in diethyl pyrocarbonate water for future cDNA preparation.
For cDNA synthesis, 1 lg of total RNA from all samples was used for enzymatic conversion of mRNA to first strand cDNA using an oligo-dT primer (Invitrogen/Life Technologies, Carlsbad, CA, USA; SuperScriptÔ First-Strand Synthesis System for RT-PCR). DNA contamination was monitored in our RNA samples by 'no reverse transcriptase' reactions which were performed in conjunction with cDNA synthesis reaction.
Primer design
Base pairs designations for rat GAPDH refer to GeneBank locus AF106860. The primers used for all GAPDH PCR reactions were: sense 5¢-ggtga aggtc ggtgt gaac-3¢ corresponding to base pairs 852-870 and antisense 5¢-ggcat cctgg gctac actg-3¢ corresponding to base pairs 1657-1675. Cath B primers were designed using GeneBank locus NM022597. The sense Cath B primer recognized an upstream rat Cath B specific mRNA sequence 5¢-tgagg acctg cttac ctgct-3¢ corresponding to base pairs 466-485. The antisense Cath B primer recognized a downstream rat Cath B specific mRNA sequence 5¢-gcagg gagtg aggca gatag-3¢ corresponding to base pairs 1141-1160.
Real-time PCR
The Roche LightCycler and the double-stranded DNA binding dye, SYBR Green I, were used to continuously monitor all PCR reactions. The LightCycler (Roche Biochemicals) is an advanced instrument that conducts rapid thermal cycling of the polymerase chain reaction. SYBR Green I dyeÔ preferentially binds to double stranded DNA and emits a fluorescent signal proportional to the DNA concentration. The reaction kinetics of this PCR reaction are represented by an amplification curve. Each amplification curve (fluorescence versus cycle number) is assigned a crossing point value (CPV), which is defined as the point of intersection between the amplification curve and the noise band. A lower CPV indicates a more rapid increase in the level of fluorescence and, thus a larger initial concentration of message. When comparing templates, those with lower CPVs contain more amplified message for the gene of interest than those with higher CPVs.
For each PCR reaction the LightCycler FastStart DNA Master PLUS SYBR Green I (Roche) reagent was used according to manufacturer's instructions in combination with primers, cDNA template, dimethyl sulfoxide and MgCl 2 at final concentrations of 0.5 lM, 10 ng, 6%, and 2 mM, respectively. After an initial 300 s, 95°C denaturation step, 40 cycles of amplification were performed (95°C for 5 s; denaturation, 65°C for 10 s; annealing, 72°C for 40 s; extension). SYBR Green I fluorescent detection of double stranded PCR products occurred at the end of each 72°C extension within each of the 40 amplification cycles. The specificity of the amplified product was confirmed by (i) the melting curve analysis and (ii) gel electrophoresis. To generate standard curves for the Cath B primer set, contusion injury templates were subjected to serial dilution. Linear regression analysis of the logarithm of the dilution factor versus the CPV generated a standard curve for each specific template. All standard curves were run concomitant with segmentand time-matched unknowns (naive, sham). The relative amount of RNA in the unknown sample was extrapolated from its CPV in relation to the standard curve. Results are reported as relative concentrations.
Northern blot analysis
Northern blot analysis was used to confirm the validity of the realtime PCR technique that we employed to examine mRNA expression. A northern blot prepared as described by Earnhardt et al. (2002) was probed with 32 P-labeled rat Cath B cDNA (gift from S. Chan, University of Chicago, IL, USA). Autoradiographic films were analyzed using Scion image analysis software. Any differences resulting from loading variability were controlled by normalizing the intensity of the Cath B mRNA signal in each sample to its mRNA signal for cyclophilin.
Tissue lysis and protein purification Lysis buffer (1 mM EDTA, 2 mM EGTA, 1 small Protease Cocktail PillÔ (Roche Molecular Biochemicals), 0.1% SDS, 1.0% IGEPAL, 0.5% deoxycholic acid, 150 mM NaCl, 20 mM Hepes, ddH 2 O, pH ¼ 7.5) was added to each sample based on the mass of the tissue (15 lL/1 mg). The tissue was homogenized on ice with a rotary pestle, returned to Eppendorf tubes and placed at 4°C for at least 30 min Samples were sonicated and spun at 800 g for 5 min at 4°C before the supernatant was collected and stored at )70°C.
Immunoblotting
Protein concentrations of the tissue homogenates were determined by bichinchoninic acid (BCA) assay (Pierce Inc., Rockford, IL, USA). Unless otherwise noted, all procedures were performed at room temperature. Eighteen micrograms of total protein were mixed with 2 · loading buffer (1 · ¼ 125 mM Tris-HCl, 100 mM dithiothreitol, 4.0% sodium dodecyl sulfate (SDS), 0.01% bromophenol blue and 10.0% glycerol) and were resolved by SDS-polyacrylamide gel electrophoresis (PAGE) on 10% Tris/HCl gels (Bio-Rad, Hercules, CA). The fractionated proteins were subsequently transferred to a 0.20-lM nylon membrane (Bio-Rad) in transfer buffer (192 mM glycine, 25 mM Tris/HCl, 10.0% methanol). Staining with ponceau red (Sigma, St. Louis, MO, USA) confirmed transfer of the proteins. Blots were blocked in 5.0% non-fat milk/ Tris-buffered saline-Tween (TBS-T) 20 mM Tris/HCl, 150 mM NaCl, 0.005% Tween 20, pH 7.5. Membranes were washed with TBS-T and incubated overnight with a polyclonal anti-Cath B antibody (1 : 1000) (Upstate Biotechnology Inc.). Membranes were washed and then incubated in 3.0% non-fat milk/TBS-T with an anti-rabbit IgG horseradish peroxidase conjugated antibody (1 : 3000) (Bio-Rad). After additional washing, bound antibodies were visualized using the chemiluminescent developing reagent ECL + (Amersham Pharmacia Biotech, UK 
Statistical analyses
In these experiments, the levels of Cath B mRNA and protein in the sham and contusion injury animals were normalized to naive levels (or control, in the case of the northern blot analysis) to generate fold induction values (± SEM) referred to as 'fold over naive' (FON). Within each segment (rostral, injury site and caudal), FON values from both the sham and contusion injury groups were analyzed via a two-way ANOVA. Each of the three different protein species (37, 30 and 25 kDa) in the immunoblot experiments required its own ANOVA. Statistically significant differences between the treatment groups were identified with post hoc tests (Tukey's for real-time PCR, immunoblots; independent t-test for northern blot analysis).
Results
Contusion-spinal cord injury increased Cath B mRNA levels Before examining the gene of interest, Cath B, the samples were tested for template integrity using the housekeeping gene GAPDH. Within each set of reactions, the CPVs for the three groups (naive, and sham and contusion injury) were not significantly different at any of the experimental time points (data not shown). Having confirmed template integrity, standard curves were used to ascertain the [mRNA] Cath B of the templates within each group. The increase in Cath B mRNA expression in both the sham and contusion injury groups was normalized against the naive levels and represented as the relative induction of (fold over naive). In all segments and at almost all time points examined, [mRNA] Cath B was increased following both sham and contusion injury (Fig. 2a) . Sham injury increased [mRNA] Cath B although to a lesser degree than the contusion injury. In both the rostral segment (FON ¼ 4.1) and injury site (FON ¼ 5.6), the sham injury induced increase peaked at 48 h post-injury and returned to near basal levels by the last time point examined (168 h). While the pattern of mRNA induction was similar in the rostral and injury segments, the caudal segment responded differently. Here, sham injury induction of Cath B mRNA expression appeared to be more robust than in the other two segments, i.e. at four of the five time points, the mRNA levels exceeded five FON.
Within the injury site, the expression of Cath B mRNA following contusion injury was significantly elevated over the sham injury values at 168 h post-injury. FON increases of 4.2, 10.7 and 19.2 were seen at 24, 48 and 168 h post-injury, respectively, with the largest recorded increase occurring at 168 h post-injury. An injury-induced elevation of Cath B mRNA expression in the injury site 24 h post-injury was demonstrated by northern analysis (Fig. 2b,c) . Northern analysis also confirmed a sham injury induced increase in mRNA expression albeit to a lesser degree than the contusion injury (Fig. 2c) .
Contusion injury also induced Cath B mRNA expression in areas beyond the injury site. Within the rostral segment, contusion injury significantly increased [mRNA] Cath B over sham injury values at 48 and 168 h post-injury. The maximum contusion injury induced increase occurred at 48 h post-injury (6.4 FON) and remained at this level (6.0 FON) until the last time point examined (168 h post-injury). Caudal to the injury site, contusion injury appeared to induce an expression of Cath B mRNA that, like the sham injury animals, was more robust than that seen in the other two segments.
[mRNA] Cath was increased at 24, 48 and 168 h post-injury (10 + FON), although a significant increase over sham injury levels occurred solely at the 48 h time point. Figure 3 displays representative immunoblots (probed with anti-Cath B antibody) for the rostral (Fig. 3a) , injury site ( Fig. 3b) and caudal (Fig. 3c) segments at 168 h post-injury. Also shown are the GAPDH loading controls. Naive samples produced faint bands while sham and contusion injury yielded broader and more intense bands for the proenzyme and active forms of Cath B. Although the most robust FON increases occurred in the injury site, increased expression of all Cath B protein species was observed in the three segments examined after both sham and contusion injury (Fig. 4) . Sham injury did increase Cath B protein levels, but the increases rarely exceeded two FON. In fact, sham injury elicited an induction with a two FON or greater at only three of 63 time points (maximum FON value was 2.3).
Cath B protein expression is elevated following spinal cord injury
Contusion injury results in significant increase over sham injury in the 37 kDa proenzyme form of Cath B at 48, 72 and 168 h post-injury at the injury site and at 24, 48, 72 and 168 h post-injury in the caudal segment (Fig. 4) . No significant change in the level of proenzyme was seen in the rostral segment. The single chain 30 kDa active form of Cath B was significantly higher following the contusion injury than in sham injury at 168 h post-injury in the rostral segment, and at 72 and 168 h post-injury in both the injury site and in the caudal segment (Fig. 4) . The double chain (25 kDa) form of Cath B in contusion injured spinal cord was significantly elevated over sham injury at 168 h postinjury in the injury site and in the rostral (but not caudal) segment (Fig. 4) .
In order to examine the relationship between the increases in Cath B [mRNA] and Cath B [protein] following sham and contusion injury, a linear regression analysis was performed for each segment. The FON mRNA (generated in the real-time experiments) was used as the independent factor and the FON protein for the Cath B proenzyme (37 kDa) was the dependent factor. There was a near linear correlation between the increases in FON mRNA and FON protein following contusion injury in the rostral (r 2 ¼ 0.941, p < 0.006), injury site (r 2 ¼ 0.971, p < 0.002) and caudal (r 2 ¼ 0.844, p < 0.028) segments, suggesting that the level of Cath B proenzyme increases linearly relative to the increases in Cath B mRNA levels after contusion injury. The same analysis of sham injury samples yielded low r 2 values, suggesting that in the case of sham injury, modest increases of Cath B [mRNA] did not translate into increases in Cath B [protein] .
Discussion
Mechanical trauma to the spinal cord initiates a complex cascade of biochemical processes that collectively contribute to neuronal and glial cell death, tissue cavitation, functional deficits and, to date, limited opportunity for restoration and/ or functional improvement. Despite the suggestion that lysosomal rupture and/or leakage may possess the greatest mechanistic potential to directly kill cells (Nixon and Cataldo 1993) , the reported increases in calpain and caspase expression and activity levels have overshadowed the characterization of lysosomal hydrolyses following contusion-SCI. While the investigation of SCI-induced changes in Cath B expression has lagged, two separate groups have reported Cath B mRNA induction 3 days after hemisection and sciatic nerve crush (Fan et al. 2001) or dorsal root avulsion (Hu et al. 2002) using microarray analysis. However, these early studies give a highly circumscribed view of the injury process as they provided the differential expression data for several hundred genes at only one post-injury time point. Our study represents the first in depth analysis of contusion injury induced changes on Cath B expression, as it examines the mRNA and protein levels at several post-injury time points and in areas in and surrounding the injury site. An examination of the expression profiles revealed significant induction following contusion injury in both the levels of Cath B mRNA (Fig. 2) and protein (Figs 3 and 4) . Importantly, the increased presence of the single chain and double chain active forms of Cath B protein illustrate that Cath B proenzyme is being processed after contusion injury (Fig. 1) . In addition, following sham injury (i.e. laminectomy and placement in the injury device), elevations in [mRNA] Cath B were observed in each segment (Fig. 2) . Cath B protein levels were also affected, but to a much smaller extent across the experimental time line (Fig. 4) . Laminectomy has been reported to decrease spinal cord blood flow, alter energy metabolism and initiate changes in membrane lipid composition (Anderson et al. 1978; Anderson and Means 1985; Demediuk et al. 1985 Demediuk et al. , 1987 . We previously reported that laminectomy alone induced MnSOD mRNA and protein expression (Earnhardt et al. 2002) . While great care was taken not to perturb the dura mater or the spinal cord during the sham injury, the increases in Cath B mRNA and protein expression confirm that laminectomy itself is an intrusive procedure. The exact mechanism(s) behind laminectomy-induced increases in Cath B mRNA and protein expression is still unknown.
As a powerful hydrolytic enzyme, Cath B likely contributes to necrotic tissue destruction via degradation of several important cellular proteins. Although little is known about (c) Fig. 3 Sham and contusion injury increase levels of Cath B proenzyme and its two active forms. Naive, sham and contusion injury samples are shown from the 168 h post-injury time point. Three bands were detected: the inactive proenzyme at 37 kDa and two active mature forms, 30 kDa (single chain) and 25 kDa (double chain). Naive samples produced very faint bands in all blots examined. In the injury site (b), the sham injury animals yielded only slightly more dense bands. The contusion injury animals, however, had noticeably more intense and broad bands. These increases also extended to areas rostral (a) and caudal (c) to the injury site. The GAPDH loading control blots are also shown for each panel. . These workers characterized the delayed neuronal death that followed the insult in the context of the 'calpain-cathepsin' hypothesis. They noted that activated calpain was localized to vacuolated and disrupted lysosomal membranes, where it acted to degrade the lysosomal membrane. This lysosomal membrane breakdown allowed activated Cath B to escape as showed by a shift of Cath B immunoreactivity from a lysosomal to a cytosolic distribution. Cath B subsequently degraded cellular substrates such as cytoskeletal and myelin proteins contributing to the selfdigestion and delayed neuronal death seen in this injury model. The events described by the 'calpain-cathepsin' hypothesis may be applicable to SCI as it has been reported that calpain expression and activity were increased following SCI (Banik et al. 1997; Ray et al. 1999; Shields et al. 2000) . However, the specific interaction between these protease systems following SCI is currently unresolved. The concomitant increase in Cath B protein levels we now report may in part reflect this postulated role of calpain, and also contribute to the general degree of protein breakdown, cellular damage and tissue loss seen following SCI.
There is also increasing evidence for Cath B involvement in apoptosis . While the executioner caspases-3 and -7 are relatively poor substrates for direct Cath B cleavage, the proinflammatory caspases-1 and -11 are readily processed (Schotte et al. 1998; Vancompernolle et al. 1998) . Furthermore, Cath B reportedly participates in several models of apoptosis including nuclear apoptosis (Vancompernolle et al. 1998) , neuronal apoptosis (Kingham and Pocock 2001) , serum deprivation induced apoptosis (Shibata et al. 1998) , cytokine induced apoptosis (Deiss et al. 1996) , and tumor necrosis factor-a induced apoptosis (Guicciardi et al. 2000; Foghsgaard et al. 2001) . There is speculation that Cath B acts to induce cytochrome c release and caspase-9 activation (Guicciardi et al. 2000) . Most likely, a universal mechanism underlying the participation of Cath B in apoptosis does not exist. Rather, several apoptotic pathways may utilize Cath B alone or in conjunction with some other factor (lysosomal, cytosolic, mitchondrial). Whether Cath B is acting upstream or downstream (or perhaps both) of cyto c release and activation of caspases-3 and -9 remains unclear. With time, these questions will be elucidated and help to further explain any role of Cath B may have in apoptotic cell death following SCI.
The impetus driving the induction of Cath B mRNA expression following contusion injury is unknown. Both the human and mouse Cath B genes have been characterized and contain putative promoter regions that exhibit characteristics of housekeeping genes (i.e. absence of TATA or CAAT boxes). However these regions also have high GC content and binding sites for the Sp1 transcription factor (Ferrara et al. 1990; Qian et al. 1991; Gong et al. 1993) . Furthermore, Yan et al. 2000 reported that the transcription factors Sp1, Sp3 and Ets1 are important factors in the regulation of Cath B transcription. While the presence of a housekeeping-like promoter suggests the constitutive expression of Cath B, the presence of these other regulatory elements coupled with the variations in Cath B mRNA levels in normal and diseased tissues (San Segundo et al. 1986) suggest that additional regulators of Cath B transcription may exist. Berquin and Sloane (1996) summarize the results of several studies reporting transcriptional regulation by agents such as phorbol ester, cytokines, interleukins and dexamethasone. At this time, the gene structure of the rat has yet to be resolved. Therefore, the transcriptional regulation of Cath B following contusion injury is outside the scope of this study.
It should be noted that Cath B mRNA expression and levels of the 37 kDa proenzyme form appeared to be greater in the caudal segment than in the rostral segment. However, the increase in the active 30 kDa form was similar in these two segments and the active 25 kDa form was higher in the rostral segment than in the caudal segment. The cause of these differences is unknown but likely reflects a variable spread of the secondary autodestructive cascade over time.
In summary, we report that expression of Cath B, a powerful and ubiquitous protease, is significantly induced by contusion injury and to a lesser extent by laminectomy only. Furthermore, this induction is seen on both the mRNA and protein level and extends beyond the confines of the original injury site. Third, active forms (30 and 25 kDa) of Cath B are also significantly elevated after contusion injury and this elevation is sustained for at least 7 days within the injury site. While its potential substrates and its exact role following contusion injury require further elucidation, by inference of the contributory role of Cath B in the pathobiology of ischemic brain injury and peripheral pathologies, we propose that Cath B is a potentially important mediator of secondary spinal cord injury.
